Stock Market Reviews

ENOV (Enovis Corporation) News

Get the latest news, insights, and market updates on ENOV (Enovis Corporation). Explore the news page 4 on MyTopStock.com for investor discussions, analysis, and real-time stock performance coverage.

• Lantheus, Enovis, Evolent Health, Repligen, and Corcept Shares Are Soaring, What You Need To Know
  A number of stocks jumped in the afternoon session after the market experienced a sharp sector rotation, as investors fled growth-oriented technology stocks and piled into value-oriented names amid growing valuation concerns. This divergence was stark: the tech-heavy Nasdaq struggled, losing 0.2%, while the Dow rallied. This shift away from tech was triggered by a series of negative catalysts in the AI sector. AI cloud provider CoreWeave slid on disappointing guidance, while chip darling Nvidia
  Nov 11, 2025 - $ENOV
• Enovis (ENOV): Assessing Valuation Following Recent Share Price Fluctuations
  Enovis (ENOV) shares saw mild movement in recent trading sessions. With little in the way of new announcements, investors seem to be weighing the company’s broader financial results and market trends for clues on future performance. See our latest analysis for Enovis. Despite recently recovering 7.8% in a single day, Enovis’s share price is still down more than 31% year-to-date, and its 1-year total shareholder return stands at a sobering -36%. This pattern suggests that while short bursts of...
  Nov 11, 2025 - $ENOV
• 3 Healthcare Stocks We Approach with Caution
  From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Despite the rosy long-term prospects, short-term headwinds such as COVID inventory destocking have caused the industry to lag recently - over the past six months, the collective 7.5% gain for healthcare stocks has fallen short of the S&P 500’s 15.3% rise.
  Nov 10, 2025 - $ENOV
• ENOV Q3 Deep Dive: Portfolio Streamlining and Innovation Drive Amid Margin Headwinds
  Medical technology company Enovis Corporation (NYSE:ENOV) reported revenue ahead of Wall Streets expectations in Q3 CY2025, with sales up 8.6% year on year to $548.9 million. The company expects the full year’s revenue to be around $2.26 billion, close to analysts’ estimates. Its non-GAAP profit of $0.75 per share was 15.6% above analysts’ consensus estimates.
  Nov 7, 2025 - $ENOV
• Enovis: Q3 Earnings Snapshot
  WILMINGTON, Del. AP) — Enovis Corporation (ENOV) on Thursday reported a loss of $571.1 million in its third quarter. On a per-share basis, the Wilmington, Delaware-based company said it had a loss of $9.99.
  Nov 6, 2025 - $ENOV
• Enovis’s (NYSE:ENOV) Q3 Sales Top Estimates
  Medical technology company Enovis Corporation (NYSE:ENOV) reported revenue ahead of Wall Streets expectations in Q3 CY2025, with sales up 8.6% year on year to $548.9 million. The company expects the full year’s revenue to be around $2.26 billion, close to analysts’ estimates. Its non-GAAP profit of $0.75 per share was 15.6% above analysts’ consensus estimates.
  Nov 6, 2025 - $ENOV
• Enovis (ENOV) Q3 Earnings and Revenues Beat Estimates
  Enovis (ENOV) delivered earnings and revenue surprises of +11.94% and +2.41%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
  Nov 6, 2025 - $ENOV
• Enovis Announces Third Quarter 2025 Results
  Diversified growth platform delivers third-quarter sales growth of 9% on a reported basis, 7% organically Third-quarter Reconstructive sales grew 12% year-over-year on a reported basis, 9% organically October divestiture of Diabetic Footcare business unit from P&R for total proceeds of up to $60 million Raising full-year 2025 adjusted EBITDA and adjusted EPS guidance Dallas, TX, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Enovis™ Corporation (“Enovis” or “the Company”) (NYSE: ENOV), an innovation-driven m
  Nov 6, 2025 - $ENOV
• Enovis (ENOV) Q3 Earnings: What To Expect
  Medical technology company Enovis Corporation (NYSE:ENOV) will be reporting earnings this Thursday before the bell. Here’s what investors should know.
  Nov 5, 2025 - $ENOV
• Enovis (ENOV): Evaluating Current Valuation After Recent Share Price Momentum
  Enovis (ENOV) shares have climbed about 10% over the past month, drawing attention from investors curious about what might be driving recent momentum. The healthcare equipment maker has seen fairly active trading in recent sessions. See our latest analysis for Enovis. After a rocky start to the year, Enovis shares have staged an impressive turnaround with a 9.6% one-month share price return and 20.3% gain over the past 90 days. While the stock is still down year-to-date and has posted a...
  Oct 27, 2025 - $ENOV